收藏切换
The molecular mechanism of Bufei Yishen decoction in intervening mitochondrial damage in chronic obstructive pulmonary disease via IP3R/GRP75/VDAC1 signaling pathway
收藏切换
PDF
Zi-han SHEN1, 2, Zheng-yuan FAN1, 3, Gao-feng LI1, 2, Li MA1, 2, Ya LI1, 3, Su-yun LI1, 4
Chinese Pharmacological Bulletin | 2026, 42(5) : 965 - 973
Less
收藏切换
Chinese Pharmacological Bulletin | 2026, 42(5): 965-973
The molecular mechanism of Bufei Yishen decoction in intervening mitochondrial damage in chronic obstructive pulmonary disease via IP3R/GRP75/VDAC1 signaling pathway
Full
Zi-han SHEN1, 2, Zheng-yuan FAN1, 3, Gao-feng LI1, 2, Li MA1, 2, Ya LI1, 3, Su-yun LI1, 4
Affiliations
  • 1Respiratory Dept, the First Affiliated Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, China
  • 2the First Clinical College, Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, China
  • 3Lab of Chinese Materia Medica Pharmacology(Respiratory Disease), the First Affiliated Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, China
  • 4Institute of Respiratory Diseases, Henan University of Chinese Medicine, Zhengzhou 450000, China
Published: 2026-05-20 doi: 10.12360/CPB202505077
Outline
收藏切换
Aim

To investigate the interventional effects of the Bu-fei Yi-shen Formula(BYF)on airway mitochondrial damage in rats with stable chronic obstructive pulmonary disease (COPD).

Methods

Forty rats were randomly assigned to four groups: Control, COPD model, BYF, and Doxofylline (DOX). From week 1 to week 8, stable COPD was induced by twice-daily exposure to cigarette smoke (30 minutes each time) combined with intranasal instillation of Klebsiella pneumoniae (once weekly). From week 9 to week 16, the control and COPD model groups were administered normal saline by gavage at a dose of 2 mL per rat. The BYF and DOX groups received 2 mL of BYF or DOX, respectively, by gavage. In week 16, tissue samples were collected. Subsequently, the degree of mitochondrial damage in lung tissues of COPD rats was evaluated from multiple dimensions, including pulmonary function, histopathology and ultrastructure of lung tissue, mitochondrial membrane potential, activities of mitochondrial respiratory chain complexes, and mRNA and protein expression levels of IP3R, GRP75, and VDAC1.

Results

Compared with the control group, the COPD group showed significantly lower pulmonary function indices(P < 0.05, P < 0.01). Histopathological examination revealed typical COPD-related alterations, including alveolar rarefaction, rupture and fusion of alveolar walls, thickening and corrugation of bronchial walls, accompanied by extensive inflammatory cell infiltration. The mitochondrial membrane potential in lung tissues of the COPD group was significantly reduced, and the activities of respiratory chain complexes II and IV decreased(P < 0.05). Serum levels of interleukin-1β(IL-1β), tumor necrosis factor-α(TNF-α), transforming growth factor- β1(TGF-β1), and interleukin-6(IL-6)were significantly elevated(P < 0.05, P < 0.01). The mRNA and protein expression levels of IP3R, GRP75, and VDAC1 in lung tissues were significantly elevated in the COPD group compared with the control group(P < 0.05, P < 0.01). These pathological alterations were alleviated to varying degrees in the treatment groups, with the BYF group demonstrating greater improvement than the DOX group.

Conclusion

BYF alleviates chronic inflammation and mitochondrial damage in rats with COPD, and its underlying mechanism may be associated with the inhibition of the IP3R/GRP75/VDAC1 signaling pathway.

chronic obstructive pulmonary disease  /  Bu-fei Yi-shen decoction  /  pulmonary function  /  mito- chondrial dysfunction  /  inflammatory reaction  /  IP3R/GRP75/VDAC1
Zi-han SHEN, Zheng-yuan FAN, Gao-feng LI, Li MA, Ya LI, Su-yun LI. The molecular mechanism of Bufei Yishen decoction in intervening mitochondrial damage in chronic obstructive pulmonary disease via IP3R/GRP75/VDAC1 signaling pathway[J]. Chinese Pharmacological Bulletin, 2026 , 42 (5) : 965 -973 . DOI: 10.12360/CPB202505077
Year 2026 volume 42 Issue 5
PDF
143
66
Cite this Article
BibTeX
Article Info
doi: 10.12360/CPB202505077
  • Receive Date:2025-12-21
  • Online Date:2026-07-16
  • Published:2026-05-20
Article Data
Affiliations
History
  • Received:2025-12-21
  • Revised:2026-03-16
Affiliations
    1Respiratory Dept, the First Affiliated Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, China
    2the First Clinical College, Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, China
    3Lab of Chinese Materia Medica Pharmacology(Respiratory Disease), the First Affiliated Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450000, China
    4Institute of Respiratory Diseases, Henan University of Chinese Medicine, Zhengzhou 450000, China
References
Share
https://castjournals.cast.org.cn/joweb/zgylxtb/EN/10.12360/CPB202505077
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT